Vaginal cancer: the role of infectious and environmental factors
Review
OA: closed
public-domain-us
AI-generated summary
This review of rare primary vaginal cancers identifies endometriosis and environmental factors like diethylstilbestrol as contributors, while highlighting herpes simplex virus and human papillomavirus as significant infectious cofactors in tumor development.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Primary cancers of the vagina are rare. They comprise 1% to 2% of all gynecologic malignancies and occur predominantly in older women. The diagnosis of primary carcinoma of the vagina requires that the cervix and vulva be intact and that no clinical evidence of other primary tumors exist. Approximately 90% of all vaginal tumors are squamous cell in type on histologic examination. Adenocarcinoma, which is much less common (2% to 4%), is seen primarily in younger women with in utero exposure to diethylstilbestrol. In addition to exposure to diethylstilbestrol, other environmental factors have been associated with the development of vaginal tumors, including chronic irritation from pessaries, previous hysterectomy for benign disease, immunosuppression therapy, cervical irradiation, and endometriosis. Infectious causes seem to play an even more pernicious role in vaginal cancer. The two agents most often implicated are herpes simplex virus and human papillomavirus. These viruses appear to serve as cofactors in the inducement of various genital cancers, working together or with environmental agents such as diethylstilbestrol and host-related genetic abnormalities. The prognosis of vaginal cancer depends on the stage of the disease, with an overall 5-year survival rate of 80% to 90% for early stages.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (21)
- Adenocarcinoma of the vagina arising in endometriosis: long-term survival following radiation therapy via crossref
- doi:10.1016/0002-9378(77)90091-6 via crossref
- doi:10.1001/jama.1986.03380050069022 via crossref
- doi:10.1002/1097-0142(197602)37:2<763::aid-cncr2820370224>3.0.co;2-t via crossref
- doi:10.1016/0002-9378(86)90464-3 via crossref
- doi:10.1056/nejm198702263160905 via crossref
- doi:10.1016/0360-3016(82)90514-4 via crossref
- doi:10.1016/0002-9378(70)90472-2 via crossref
- doi:10.1002/1097-0142(197503)35:3<787::aid-cncr2820350334>3.0.co;2-k via crossref
- doi:10.1016/0002-9378(77)90445-8 via crossref
- doi:10.1016/0002-9378(73)90391-8 via crossref
- doi:10.1016/0090-8258(78)90037-9 via crossref
- doi:10.1002/1097-0142(197403)33:3<647::aid-cncr2820330309>3.0.co;2-s via crossref
- doi:10.1002/ijc.2910350105 via crossref
- doi:10.1002/1097-0142(196607)19:7<1026::aid-cncr2820190718>3.0.co;2-# via crossref
- doi:10.1016/s0140-6736(86)92067-2 via crossref
- doi:10.1038/bjc.1983.243 via crossref
- doi:10.1136/jcp.37.11.1201 via crossref
- doi:10.1016/0165-4608(89)90084-8 via crossref
- doi:10.1016/s0002-9378(16)33683-3 via crossref
- doi:10.1002/ijc.2910410408 via crossref
Source provenance
- crossref
- last seen: 2026-09-04T06:34:21.339004+00:00
- europepmc
- last seen: 2026-10-18T09:30:06.152893+00:00
- pubmed
- last seen: 2026-10-08T21:03:44.483075+00:00
- unpaywall
- last seen: 2026-10-18T06:28:46.490043+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine